Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases
Objective Evaluate spondyloarthritis (SpA) incidence in inflammatory bowel diseases (IBD) between patients treated with biological disease-modifying antirheumatic drugs (bDMARDs) and conventional DMARDs (cDMARDs) and define risk factors associated with SpA development.Methods Retrospective cohort st...
Збережено в:
| Автори: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMJ Publishing Group
2024-02-01
|
| Серія: | RMD Open |
| Онлайн доступ: | https://rmdopen.bmj.com/content/10/1/e003820.full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|